Jinsheng Ren
Inventor
Stats
- 1 US patents issued
- 31 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 31 US Applications Filed
- 15 Total Citation Count
- Apr 4, 2024 Most Recent Filing
- Sep 30, 2010 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| JIANGXI ADVANCE NANOFOBER S&T CO., LTD. | 2
| 2010
|
| Shenzhen Hifuture Electic Co., Ltd. | 1
| 2011
|
| JIANGXI ADVANCE NANOFIBER S&T CO., LTD. | 3
| 2010
|
Inventor Addresses
| Address | Duration |
|---|---|
| Jiangsu, CN | Jan 05, 23 - Jan 23, 25 |
| Nanchang, CN | Jun 27, 13 - Dec 08, 15 |
| Nanjing, CN | Jan 20, 22 - Feb 06, 25 |
| Nanjing, Jiangsu, CN | May 11, 23 - Mar 06, 25 |
| Shanghai, CN | Nov 02, 23 - Nov 02, 23 |
| Shenzhen, CN | Feb 13, 14 - Feb 13, 14 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 17 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 14 |
| C07D: | HETEROCYCLIC COMPOUNDS | 5 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0075,006 | 2025 | ANTI-GUCY2C NANO-ANTIBODY AND APPLICATION THEREOF | 0 |
| 2025/0042,994 | 2025 | CD19 ANTIBODY AND APPLICATION THEREOF | 0 |
| 2025/0026,844 | 2025 | ANTI-BCMA NANOBODY AND USE THEREOF | 0 |
| 2025/0009,847 | 2025 | IL-15 MUTANT FUSION PROTEIN PHARMACEUTICAL COMPOSITION | 0 |
| 2024/0343,811 | 2024 | CD16 ANTIBODY AND USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.